MENU
+Compare
DARE
Stock ticker: NASDAQ
AS OF
Jul 11 closing price
Price
$2.52
Change
+$0.13 (+5.44%)
Capitalization
22.26M

DARE Dare Bioscience Inc. Forecast, Technical & Fundamental Analysis

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health... Show more

Industry: #Biotechnology
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for DARE with price predictions
Jul 11, 2025

DARE's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for DARE moved out of oversold territory on July 11, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In of the 34 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where DARE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

DARE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on DARE as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for DARE turned negative on June 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

DARE moved below its 50-day moving average on June 17, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for DARE crossed bearishly below the 50-day moving average on June 24, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DARE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for DARE entered a downward trend on July 09, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. DARE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.267) is normal, around the industry mean (17.292). P/E Ratio (0.099) is within average values for comparable stocks, (58.926). DARE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.456). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (833.333) is also within normal values, averaging (272.270).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DARE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

DARE is expected to report earnings to fall 104.66% to 2 cents per share on August 08

Dare Bioscience Inc. DARE Stock Earnings Reports
Q2'24
Est.
$0.02
Q1'25
Missed
by $0.48
Q4'24
Missed
by $0.65
Q1'24
Missed
by $0.01
Q4'23
Beat
by $0.02
The last earnings report on May 13 showed earnings per share of -50 cents, missing the estimate of -1 cents. With 8.23M shares outstanding, the current market capitalization sits at 22.26M.
A.I. Advisor
published General Information

General Information

a provider of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3655 Nobel Drive
Phone
+1 858 926-7655
Employees
26
Web
https://www.darebioscience.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JG11.700.59
+5.31%
Aurora Mobile Limited
CSGP85.43-0.62
-0.72%
CoStar Group
LLYVA76.51-0.67
-0.87%
Liberty Media Corp
NKSH29.42-0.26
-0.88%
National Bankshares
SION20.43-0.51
-2.44%
Sionna Therapeutics Inc

DARE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DARE has been closely correlated with AZTR. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if DARE jumps, then AZTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DARE
1D Price
Change %
DARE100%
+5.23%
AZTR - DARE
73%
Closely correlated
-8.39%
CYTK - DARE
42%
Loosely correlated
+1.15%
AXON - DARE
39%
Loosely correlated
-0.46%
AMRN - DARE
34%
Loosely correlated
-2.66%
SNTI - DARE
32%
Poorly correlated
-7.76%
More

Groups containing DARE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DARE
1D Price
Change %
DARE100%
+5.23%
DARE
(2 stocks)
56%
Loosely correlated
-1.58%